Cannabinoids have been used in tentative
studies, demonstrating their ability to greatly reduce tumors, and
cure cancer, in mice.
The justification currently holding the
most ground is that cannabis is a plant, and cannot be carefully
regulated because of the great chemical variability that is found
between individual plants.
And while one could understand the desire to maintain the strict regulation standards, the fact is that attempts to fix the purity problem have severely reduced its medical potency, and process has no real benefit. Control doesn't make the substance any safer because it isn't dangerous in the first place. Its toxicity is comparable to water.
Yes, an individual could make themselves feel
very unwell if they surpass their stomach's physical limits with any
substance.
Unfortunately, most of the investigation of the medical applications for cannabis are being done illegally and in secret.
The controversy, even according to the researchers themselves, is the main barrier to conducting scientific studies of the plant's properties. As a substance classified as a Schedule I drug, even research on cannabis is an illegal activity.
Many sick individuals simply cannot wait for governments to get over their hang-ups, nor can the expectation that they should be justified.
Currently, patients are required to
exhaust the potential of other anti-nausea medications, many of
which are less safe, in order to be prescribed medical marijuana.
The problem is that the tentative
separation has only resulted in a THC that has a profoundly
diminished efficacy, and leaves behind the other 88 healing
cannabinoids.
The overwhelming majority of patients are using the plant's psychoactive properties to mediate the deleterious effects of radiation. The direct effect of THC on ailments themselves is a largely unexplored field.
As research moves forward, the
artificially manufactured cannabinoids will inevitably increase in
quality, eliminating the purity problems, and paving the way for the
kind of precise control that will make regulators comfortable
distributing the product.
|